Catheter Precision Inc (VTAK)
0.55
+0.02
(+4.62%)
USD |
NYAM |
May 02, 11:49
Catheter Precision Enterprise Value: 0.6003M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.6003M |
| April 30, 2024 | 0.776M |
| April 29, 2024 | 0.8601M |
| April 26, 2024 | 0.7635M |
| April 25, 2024 | 0.7844M |
| April 24, 2024 | 0.9737M |
| April 23, 2024 | 0.0702M |
| April 22, 2024 | -0.0108M |
| April 19, 2024 | -0.0389M |
| April 18, 2024 | 0.2633M |
| April 17, 2024 | -0.0252M |
| April 16, 2024 | 0.0952M |
| April 15, 2024 | 0.127M |
| April 12, 2024 | 0.2959M |
| April 11, 2024 | -0.0108M |
| April 10, 2024 | 0.3375M |
| April 09, 2024 | 0.5193M |
| April 08, 2024 | 0.4436M |
| April 05, 2024 | 0.4511M |
| April 04, 2024 | 0.4087M |
| April 03, 2024 | 0.6185M |
| April 02, 2024 | 0.4049M |
| April 01, 2024 | 0.3921M |
| March 28, 2024 | 0.2997M |
| March 27, 2024 | 0.33M |
| Date | Value |
|---|---|
| March 26, 2024 | 0.3307M |
| March 25, 2024 | 0.4137M |
| March 22, 2024 | 0.436M |
| March 21, 2024 | 0.5647M |
| March 20, 2024 | 0.6526M |
| March 19, 2024 | 0.4814M |
| March 18, 2024 | 0.4814M |
| March 15, 2024 | -0.1668M |
| March 14, 2024 | 1.008M |
| March 13, 2024 | 0.7389M |
| March 12, 2024 | 1.036M |
| March 11, 2024 | 0.9052M |
| March 08, 2024 | 0.6242M |
| March 07, 2024 | 0.6171M |
| March 06, 2024 | 0.5476M |
| March 05, 2024 | 0.2728M |
| March 04, 2024 | 0.4134M |
| March 01, 2024 | 0.1323M |
| February 29, 2024 | 0.0901M |
| February 28, 2024 | 0.0557M |
| February 27, 2024 | -0.219M |
| February 26, 2024 | -0.4298M |
| February 23, 2024 | -0.4994M |
| February 22, 2024 | -0.4572M |
| February 21, 2024 | -0.4509M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-31.48M
Minimum
Aug 13 2019
32.57M
Maximum
Jun 07 2021
-5.638M
Average
-4.180M
Median
Jan 05 2022
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 990.24M |
| Retractable Technologies Inc | -12.89M |
| InfuSystems Holdings Inc | 194.31M |
| Xtant Medical Holdings Inc | 128.19M |
| Asensus Surgical Inc | 43.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.669M |
| Revenue (Quarterly) | 0.128M |
| Total Expenses (Quarterly) | 2.725M |
| EPS Diluted (Quarterly) | 1.21 |
| Gross Profit Margin (Quarterly) | 94.53% |
| Profit Margin (Quarterly) | -522.7% |
| Earnings Yield | -4.37K% |
| Normalized Earnings Yield | -460.93 |